The Leadership Team at APIM Therapeutics, composed of the CEO, Chief Scientific Officer, Chief Medical Officer, and Chief Financial Officer, spearheads strategic decision-making and oversees the company's operations. Their collective responsibilities include guiding scientific research, clinical development, financial planning, and overall corporate strategy to advance the development of proprietary peptide drugs targeting PCNA.
View all